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Object. Aim of our study was to establish some peculiar features of M´ eni` ere’s Disease (MD) in a group of elderly MD patients,
in which the ﬁrst vertigo spell happened when over 65 years old. Material and Methods. We analyzed a group of 73 younger than
65-years-old and a group of 30 elderly MD patients. All patients underwent a neurotological evaluation, an anamnestic evaluation
including a lifetime history of migraine, and blood withdrawal for autoantibody screening. Results.S o m ed i ﬀerences were found
between elderly and younger MD patients. Elderly MD patients presented a higher prevalence of Tumarkin attacks and a lower
prevalence of lifetime history of migraine; moreover, they presented a faster develop of hearing loss and vertigo spells than a
subgroup of 32 younger patients matched for the duration of illness. Conclusions. Some clinical features of MD in elderly have
been pointed out. Particularly, the lower rate of migrainous history and positivity for autoantibodies often associated with MD, in
our opinion, support the hypothesis of a vascular disorder acting as a predisposing factor for MD in elderly.
1.Introduction
M´ eni` ere’s Disease (MD) is an inner ear disorder, charac-
terized by recurrent episodes of rotational vertigo, coupled
with ﬂuctuating hearing loss and tinnitus. According to
The American Academy of Otolaryngology-Head and Neck
Surgery Foundation (AAO-HNSF), the diagnostic criteria
for deﬁnite MD are the presence of two or more episodes
of vertigo of at least 30min with hearing loss plus tinnitus
a n d / o ra u r a lf u l l n e s s[ 1].
The prevalence of MD is 190 cases per 100000, and this
value increases in the elderly [2].
The commonly accepted pathogenesis of MD is a raised
endolymphatic pressure (hydrops), although a direct rela-
tionship between MD and endolymphatic hydrops is
unproven [3, 4]. In the last few decades, several studies have
analyzed possible etiological mechanisms and correlations
with other diseases [5–14]. Epidemiological studies support
the possibility of a correlation between MD and migraine.
MD patients present a prevalence of migraine between 43%
and 56%, which is signiﬁcantly higher than the estimated
10% in the normal population [10, 11].
Migraine is considered per se a causal factor of recurrent
vestibular symptoms, including both true rotational vertigo
and subjective vertigo [5–15]; there is clinical evidence that
migraine may damage the inner ear causing permanent
hearing loss or vestibular deﬁcit [16] ,a n di nc h i l d r e na
ﬂuctuating hearing loss has been considered as a migraine
equivalent [17]. It has been supposed that the migrainous
vasospasm may induce damage in the inner ear, acting as a
disrupting factor for a secondary MD [9].
Since higher levels of circulating immunocomplexes and
elevatedautoantibodytitershavebeenfoundinMDpatients,
the pathophysiology of MD has been supposed to be linked
to an autoimmune disorder [18, 19]. An association with
the PTPN22 T allele, which has been described in other
autoimmune diseases, has been reported in bilateral MD;
these data support the idea of an inﬂammatory mechanism
common to diﬀerent autoimmune diseases [20].
Unilateral MD patients have a higher level of antiphos-
pholipid antibodies than the normal population. The
antiphospholipidantibodies,anticardiolipin,β2 glycoprotein
1 autoantibodies, and Lupus-Like anticoagulant are cor-
related with thrombotic syndrome. The antiphospholipid2 Journal of Aging Research
antibodies could mediate vascular diseases by a thrombotic
mechanism [19].
Since 10% of cases present a familiar distribution, the
genetics of MD has been studied [21–23], considering
both possibilities of a single gene mutation provoking the
syndrome (COCH gene encoding cochlin and chromosome
12p13.3 mutation) [24, 25] and acting as a predisposing
factor (HLA B-27, Antiquitin) [26, 27]. Anticipation in
familial MD has been described, consisting of an earlier
age of onset in successive generations and more severe
clinical manifestations. The genetic model may be linked to
a trinucleotide repeat disorder; this mechanism is similar to
other neurological diseases such as spinocerebellar atrophy
6 and myotonic dystrophy in which a channelopathy is
supposed [14].
New studies on M´ eni` ere’s disease (MD) in elderly
patients may help bring about a prolongation of lifespan in
the last decades. An earlier study on Japanese MD subjects
reported a peak of onset around the ﬁfth decade for men
and in the fourth decade for women [28], with a 10-
year shift from previously reported data. The neurotological
evaluation of elderly MD patients found vestibular clinical
features in the elderly similar to young and middle-aged MD
patients except for a higher incidence of oculomotor system
alterations [28]. A higher prevalence of MD in patients over
65 years has also been reported in a European population,
both for a reactivation of MD and for a “de novo” MD. In
elderlyMDpatients,ahighincidenceinwomenandof“drop
attacks” has been described [29], and Tumarkin episodes
maycausesuddenfalls.TheTumarkinattacks[30]arecaused
by an acute stimulation of an otolith organ in patients
with MD or delayed endolymphatic hydrops; in some cases,
diﬀerential diagnosis with drop attack is a puzzling dilemma
[31].
The aim of our study was to establish some possible
p e c u l i a rc h a r a c t e r i s t i c so fM Di nag r o u po fe l d e r l yM D
patients compared with younger MD patients.
2.MaterialsandMethods
2.1. Subjects. We studied 103 deﬁnite MD patients consecu-
tively recruited at the outpatient facilities of the Vestibular
Disorders Ambulatory at San Raﬀaele Hospital in Milan,
from January 2006 until April 2011. The diagnosis of def-
inite MD was established according to AAO-HNSF criteria
(American Academy of Otolaryngology, 1995).
Patients were divided into two groups in relation to age
of onset of MD. A group of 73 younger MD patients: 41 were
femalesand32weremales,meanagewas 50.1±12 years,and
ageofonsetofMDwas 39±9.7 years.Twosubjectspresented
bilateral MD. Delayed hydrops were excluded.
Between these patients, a subgroup of 32 subjects
presented a lower than 6 years history of vertigo (3.4 ± 1.8
years). Mean age was 39.6 ±10.3. Nineteen were females.
The second group was composed of 30 elderly MD
patients: 13 were females and 17 males and mean age
was 72±4.3 years. All of them presented a lower than 6 years
history of attacks and presented unilateral MD. Exclusion
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Figure 1: The 3 diﬀerent types of audiometric exams; on x-axis are
the represented frequencies, on y-axis, hearing loss in decibels (db).
criterion for this second group was a lifetime history of
previous vertigo episodes before 65 years of age. First vertigo
attack happened 2.7 ±2.3 years before the evaluation.
Allpatientsunderwentafullneurotologicalexamination,
includingaudiometrictestat1dbprecision,analysisofspon-
taneous, and evoked nystagmus with video-oculography
(VOG 25, Interacoustics). Anamnesis of Tumarkin attacks
and familiar history of vertigo (till grandparents) were
assessed by a senior neurotologist. All of them performed a
Central Nervous System MRI.
Morfology of audiometric exam was divided in three
groups (Figure 1).
(1) Type 1: low frequencies sensorineural hearing loss
with normal hearing threshold on high frequencies.
(2) Type 2: reduced hearing threshold at all frequencies,
increased at low and high frequencies (“peaked
curve”).
(3) Type 3: reduced hearing at all frequencies with a
threshold below 60db (“ﬂatcurve”).
A lifetime history of migraine was established by a senior
neurologist, according to the International Headache Society
(IHS) criteria (Headache Classiﬁcation Sub-Committee of
the International Headache Society, 2004) [32].
An autoantibody screening (anti nucleus, mitochondrial,
smooth muscle, thyroid, antiphospholipid autoantibodies,
and Rheumatoid Factor) was assessed.
The study was approved by our Ethics Committee and
patients signed informed consent.
2.2. Statistical Analysis. Continuously distributed variables
were described by the mean and standard deviation (SD);
categorical variables were described by frequencies and
percentages. The signiﬁcance of any diﬀerence between
groups was evaluated by t-test for independent samples. A
multiple linear regression analysis was performed in order to
investigate the correlation between variables.Journal of Aging Research 3
Table 1: Demographic and clinical data in elderly and younger MD
subjects.
Young MD
(n = 73)
Elderly
MD
(n = 30)
P value
Age 50.1±12 72±4.3 P≤0.01
Age at onset of MD 39 ±9.7 69.3 ±4.1 P ≤0.01
Migraine 38/73
(51%)
4/30
(20%)
χ2 =8.93
P = 0.03
Positive autoantibody
screening
25/73
(33.8%)
3/30
(20%)
χ2 =6.31
P = 0.02
Tumarkin 7/73
(9.6%)
11/30
(36-7%)
χ2 =10.8
P ≤0.01
Familiar history of vertigo 8/73
(10.9%) 2/30 (6%) χ2 =0.5
P = 0.5
Number of spells in the last
6m o n t h s 5.5 ±3.71 0 .4 ±5.4 P ≤0.05
3. Results
Results are presented in Table 1. The elderly MD patients
presented a lower rate of lifetime history of migraine (P =
0.04) and positive autoantibody screening (P = 0.04)
than younger MD subjects. Only 1 patient with migraine
presented positive autoantibodies.
At the time of examination, 12 of 20 (60%) elderly
MD subjects presented a sensorineural hearing loss at all
frequencies with a “ﬂat” audiogram, while 8 (40%) had
a peak at central frequencies. The elderly MD patients
showed a higher prevalence of Tumarkin attacks (P<0.01)
and lower for lifetime history of migraine (P = 0.03)
and positive autoantibodies (P = 0.02). Moreover, they
presented a higher rate of vertigo spells in the 6 months
before evaluation. Ten of 30 (33.3%) elderly MD patients
presented microischemic lesions at MRI compared with 10
of 73 (13.7%) in the younger group (χ2 = 5.2, P = 0.02);
nine of the 10 subjects in the last group were migraineurs.
Hearing loss (mean value for frequencies between 250
and 2000Hz) at diagnosis was 64.6 ± 8.8db in elderly and
53.8 ± 13.8i ny o u n g e rM Ds u b j e c t s( P = 0.001), while
the unaﬀected ear (the two subjects with bilateral MD were
not included) was respectively, 18.2 ± 4.5a n d1 6 .3 ± 3.3
(P = 0.04).
Inthewholegroupof103subjects,acorrelationhasbeen
established between Tumarkin attacks and lifetime history of
migraine (P = 0.05) and between positivity of at least one of
the autoantibodies and hearing loss (P = 0.05).
InordertodemonstrateapossiblefasterevolutionofMD
in elderly, we compared the results of hearing loss in aﬀected
and unaﬀected ear and the number of vertigo spells in the
last 6 months in the group of elderly and in the subgroup of
younger MD subjects with a shorter than 6 years history of
vertigo attacks. Results and statistics are summarized in the
Table 2.
In the group of elderly MD subjects 24, (80%) presented
a type 3 audiogram and 6 (20%) a type 2 audiogram; while
between the 32 younger MD subjects, 12 (37%) presented a
type 3 audiogram, 14 (44%) a type 2, and 6 (19%) a type 1
audiogram (χ2 = 13.1, P = 0.001).
4. Discussion
In our sample of 103 MD subjects, 30 (29%) presented onset
of symptoms when over 65 years of age. Our data are in
the range of other previous studies [29, 33]. In the sample
of elderly MD patients, males were more represented (17 of
30, 56%), the opposite than in the younger sample 32 of 73
(44%), although result has no statistical evidence (P = 0.2).
Elderly subjects presented a more “aggressive” evolution
of MD; these subjects referred a higher rate of vertigo
spells and had a faster evolution toward a “ﬂat” audiometric
threshold (with higher values of hearing loss in the aﬀected
side) compared with the subgroup of 32 younger MD
subjectsmatchedforyearssincetheonsetofﬁrstsymptom.It
should be noted that the unaﬀected ear in elderly presented a
lower hearing threshold than younger subjects, but the mean
diﬀerence was only 2.1db. As far as we know, no previous
data have been published on a possible faster evolution of
MD in elderly.
Elderly patients presented a higher rate of Tumarkin
attacks, and on the topic our results conﬁrm previously
published works; a possible explanation may be linked to a
lower compliance of otolithic structuresto hydrops in elderly
“de novo” MD patients [29, 34]. Alternatively, Tumarkin
attacks may be linked to brief periods of ischemia or
vasospasm of the anterior vestibular artery, which provides
blood to the utricle, vestibular ganglion, and posterior
semicircular canal. This branch is supposed to be more
fragile than the posterior vestibular artery since the latter
probablyhasamajornumberofintraosseouscollaterals[35].
If so, the pathophysiology of Tumarkin should not diﬀer
signiﬁcantly from that of paroxysmal positional vertigo,
whose prevalence is signiﬁcantly increased in the elderly.
The etiology of MD is at present a puzzling dilemma,
and it seems probable that it consists of diﬀerent pathologic
conditions leading to the same cluster of symptoms. All our
elderly subjects fulﬁll the diagnostic criteria for deﬁnite MD,
but in the two groups, some clinical diﬀerences regarding
possible “predisposing factors” may be noted, underlining
the polymorphic nature of MD.
As previously discussed, epidemiological evidence has
been found regarding an association between MD and
migraine or autoimmune disorders; moreover, a genetic
predisposition may be supposed, since around 10% of MD
subjects refer of having at least 1 familiar with recurrent
vertigo episodes.
InelderlyMDsubjects,wefoundalowerrateofpositivity
for autoantibodies, lifetime history of migraine and familiar
history of recurrent vertigo.
Theseresultsandthepresenceofahigherrateofmicrois-
chemic lesions are not inconsistent with the hypothesis of a
diﬀerent etiological mechanism, possibly related to vascular
disorders, in the genesis of MD in elderly patients, and
further studies should assess the question.
Elderly patients commonly present other vascular disor-
ders, and these factors could inﬂuence the clinical features4 Journal of Aging Research
Table 2: Values of hearing loss in aﬀected and unaﬀected ear (mean value of frequencies between 250 and 2000hz), number of vertigo spells
in the last 6 months, and years since the ﬁrst attack in the group of 30 elderly subjects and in the subgroup of 32 patients with a lower of 6
years history of vertigo.
Elderly MD subjects
(n = 30)
Younger MD subjects
(n = 32) P value
Years since ﬁrst vertigo 2.7 ±2.33 .4 ±1.80 . 0 8
Hearing loss aﬀected ear 64.7 ±8.1db 48.2 ±10.9db 0.001
Hearing loss unaﬀected ear 18.2 ±4.5db 16.3 ±3.3db 0.04
N◦ of crises in the last 6 months 6.5 ±3.71 0 .4 ±5.5 0.002
of MD. The presence of vascular problems in elderly MD
patients has been found in other studies, and a higher
prevalenceofhypertensioninMDpatientshasbeenreported
in a population of 131 subjects [36]. Other studies have
focused on a correlation between carotid atheromatosic
changes and peripheral vestibular disorders, in some cases
mimicking MD [37, 38].
A more recent work reported the presence of microis-
chemic lesions of brain white matter in 31% of MD subjects,
while only 25% of BPPV subjects, condition in which
a vascular disorder has been demonstrated to act as a
predisposing factor [39].
As a ﬁnal consideration, MD in elderly patients may
produce more disrupting results, since most of them present
decreased postural and gait control due to a physiological
reduction of the motor and sensorial system. Functional bal-
ance in elderly subjects with chronic vestibular disorders is
worsened when associated with aging, concurrent disorders,
use of multiple medications, central vestibular syndromes,
mobility, and gait impairments.
5. Conclusions
Hydrops may be more related to a pathophysiological mech-
anism rather than a speciﬁc etiology. Our data support the
hypothesis of diﬀerent, possibly more related to a vascular
disorder, predisposing factors for MD in elderly patients
compared with MD in younger subjects.
Our data conﬁrm previous works reporting a higher
prevalence of Tumarkin attacks in elderly MD subjects;
the lower rate of positive autoantibodies may be related
to diﬀerent etiopathological mechanisms of MD in elderly
subjects.
Moreover, our data support the hypothesis of a more
aggressive pattern in over-65 de novo occurrence MD
patients.
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